Merck (NYSE: MRK)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Merck Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Merck Company Info
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.
News & Analysis
3 Reasons to Buy Merck Stock
This list is by no means exhaustive.
My Oh My, Merck Stock Is a No-Brainer Income Stock to Buy
The pharmaceutical company has outperformed the market over the past five years.
Is Merck Stock a Buy Now?
There's a lot to like about this blue-chip company, but it has its problems, too.
How Many Blue Chip Stocks Are There?
Blue chip stocks are, by nature, made up of an exclusive group of companies. But how many are there and how many can exist at one time?
Merck and AbbVie Are Facing Big Patent Cliffs, But Here's Why Both Are Still Buys
Both companies are facing significant patent cliffs, but they've been preparing for this moment.
Is Merck Stock a Top Buy Right Now?
The drugmaker is still a work in progress.
Top Commercial Real Estate Stocks
Commercial real estate stocks offer opportunities to get involved with some of the most interesting businesses in the world.
What Is the Fortune 100?
Valuation
Podcast Episodes
The Top Healthcare Stocks of 2018: Can They Continue in 2019?
These healthcare stocks crushed the S&P 500's return last year, but that doesn't guarantee they'll be top performers in 2019.
News! News! News! Here's What's Happened in Healthcare Last Week
From a big-time patent settlement between Merck & Co. and Bristol-Myers Squibb, to Johnson & Johnson's earnings, to Aetna and Humana's $37 billion merger bust, we dive into the details behind last week's biggest healthcare stories.
Patent Palooza: One Patent Battle in Hep C, And Another Patent Brawl Brewing On Capitol Hill
Merck, Gilead Sciences, and Ionis get a verdict in their patent suit, and Congress calls for a patent review of Medivation's Xtandi.
Earnings Transcripts
Merck (MRK) Q3 2023 Earnings Call Transcript
MRK earnings call for the period ending September 30, 2023.
Merck (MRK) Q2 2023 Earnings Call Transcript
MRK earnings call for the period ending June 30, 2023.
Merck (MRK) Q1 2023 Earnings Call Transcript
MRK earnings call for the period ending March 31, 2023.
Merck (MRK) Q4 2022 Earnings Call Transcript
MRK earnings call for the period ending December 31, 2022.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.